La vendita allo scoperto per Tyra Biosciences dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Tyra Biosciences. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Tyra Biosciences (NASDAQ:TYRA) Azioni, Report sulle vendite allo scoperto

Tyra Biosciences

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology The Company's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNAPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. Its lead product candidate is TYRA 300, an FGFR3 selective inhibitor with an initial focus on patients with metastatic urothelial carcinoma of the bladder and urinary tract (mUC).

Tyra Biosciences Inc

Earnings

News

SBSW

Sibanye Stillwater Q3 Adjusted EBITDA $184M, Up 9% Year-On-Year

Legal

NFLX

Reuters Reported France's PNF Financial Prosecutor Body Has Carried Out Searches Today At Netflix France, Amsterdam Offices, Citing Judicial Source

Phunware Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) experienced a significant surge in its stock price, climbing 10.27% during pre-market trading on Tuesday, as per <a href="https://pro.benzinga.com">Benzinga Pro</a>. 
What Happened: The stock&#8217;s rise occurred just one day before the U.S. Elections. This increase comes as the company remains linked to former President Donald Trump, having managed his 2020 reelection campaign&#8217;s mobile app.
On Friday, Phunware also revealed that Troy Reisner, the<a href="https://www.benzinga.com/markets/equities/24/11/41712003/trump-linked-phunwares-leadership-shuffle-continues-cfo-joins-ceo-in-exit-queue"> Chief Financial Officer</a>, intends to resign between Nov. 15 and Nov. 30. The company emphasized that Reisner&#8217;s departure is not due to any disagreements over business operations or financial practices. A search for a new CFO is underway. Post the announcement, on Monday, PHUN dropped by 10% during pre-market.
During this transition, Interim CEO Stephen Chen will collaborate with Brendhan Botkin, Vice President of Accounting and Financial Reporting, to oversee the roles of principal financial officer and principal accounting officer. Last month, Phunware announced the<a href="https://www.benzinga.com/news/24/10/41521091/trump-linked-phunware-stock-falls-as-ceo-exits-what-you-need-to-know"> resignation of CEO</a> Michael Snavely, with Stephen Chen assuming the role of interim CEO.
See Also: <a href="https://www.benzinga.com/markets/equities/24/11/41734592/palantir-trump-media-hims-hers-health-nxp-semiconductors-and-tesla-why-these-5-stocks-are-on-inv?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">PLTR, DJT, HIMS, NXPI, TSLA: Top 5 Trending Stocks Today</a>
Why It Matters: Phunware&#8217;s stock has been subject to fluctuations, often influenced by its ties to Trump-related ventures. On Oct. 15, Phunware&#8217;s shares surged amid market momentum and its association with <a href="https://www.benzinga.com/news/24/10/41339350/phunware-stock-skyrockets-amid-trump-association-and-market-momentum-whats-going-on">Trump Media &amp; Technology Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>), which launched its Truth+ streaming service. The platform is set to expand with an iOS app and availability on platforms like Apple TV and Amazon Fire.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41734897/elon-musks-doge-department-mention-gives-dogecoin-boost-to-top-of-daily-gainers-memecoin-s?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Elon Musk&#8217;s &#8216;DOGE&#8217; Department Mention Gives Dogecoin Boost To Top Of Daily Gainers: Memecoin Spikes 6%</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Equities

Pre-Market Outlook

Markets

General

PHUN

Trump-Linked Phunware Stock Is Surging 10% In Pre-Market: What's Going On?

Guidance

Health Care

Fresenius Medical Care Also Reconfirms Its Targets To Achieve An Operating Income Margin Of 10%-14% By 2025

Fresenius Medical Care Confirms Its Outlook For Fiscal 2024 And Expects Revenue To Grow By A Low- To Mid-single Digit Percent Rate, With Operating Income To Grow By 16%-18% Versus Prior Guidance Of Growth By A Mid- To High-teens Percent Rate

Fresenius Medical Care (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMS#NYSE">FMS</a>) reported quarterly earnings of $0.73 per share which beat the analyst consensus estimate of $0.35 by 108.57 percent. This is a 28.07 percent increase over earnings of $0.57 per share from the same period last year. The company reported quarterly sales of $4.76 billion which missed the analyst consensus estimate of $4.89 billion by 2.67 percent. This is a 3.57 percent decrease over sales of $4.94 billion the same period last year.

Fresenius Medical Care Q3 2024 Adj EPS €0.73 May Not Be Comparable To €0.35 Estimate, Sales €4.76B Miss €4.89B Estimate

Alex Karp, CEO of Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) has cautioned that Europe could face ruin if it does not adopt <a href="https://www.benzinga.com/topic/artificial-intelligence">artificial intelligence (AI) innovation</a>.
What Happened: &#8220;As America once again forges ahead, our allies and partners in Europe are being left behind,&#8221; Karp stated in a letter to shareholders on Monday.
His warning came as <a href="https://www.benzinga.com/news/earnings/24/11/41730179/palantir-q3-earnings-revenue-beat-eps-beat-customers-up-39-raises-guidance-results-driven-by-unrele">Palantir&#8217;s business growth accelerates</a>, surpassing expectations due to the robust demand for advanced AI technologies from&nbsp;U.S. government and commercial customers.
The company&#8217;s revenue in the&nbsp;last quarter reached a record&nbsp;$726 million,&nbsp;a 30% increase from the&nbsp;same period last year.
Palantir&#8217;s year-over-year revenue growth rate&nbsp;has increased over the past&nbsp;six quarters, rising from 13%&nbsp;in the second quarter of 2023 to 30% in the third quarter of 2024.
See Also:&nbsp;<a href="https://www.benzinga.com/news/24/10/41663190/openai-rolls-out-chatgpt-search-google-shares-slide?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">OpenAI Rolls Out ChatGPT Search, Google Shares Slide</a>
In his letter, Karp attributed this growth to&nbsp;early and decades-long investment in&nbsp;technical infrastructure, which is now making large language models valuable to large enterprises.
Palantir has also joined the S&amp;P 500, a goal many thought was fanciful. The company&#8217;s entry into the index was&nbsp;made possible by the strength&nbsp;of its&nbsp;business and expanding demand for&nbsp;its software, he stated.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
Why It Matters: Karp&#8217;s warning to Europe comes in the wake of Palantir&#8217;s record-breaking Q3 2024 results, which were driven by an &#8220;unrelenting AI demand that won&#8217;t slow down.&#8221;
The U.S. market remains the&nbsp;core of Palantir&#8217;s business, where institutions have responded&nbsp;most rapidly to the promise&nbsp;of AI.
The release of Palantir&#8217;s&nbsp;newest platform, AIP, has transformed&nbsp;the business, with U.S. revenue reaching $499 million in the third quarter, a 44% increase&nbsp;compared to the same period&nbsp;a year earlier.
Wedbush analyst Dan Ives referred to Palantir as the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41732827/messi-of-ai-wall-street-analyst-gushes-over-robust-earnings-from-palantir">&#8220;Messi of AI&#8221; following the company&#8217;s</a> robust earnings. The company&#8217;s customer count grew 39%, and it raised its full-year outlook across all metrics.
Palantir&#8217;s AI gamble has also paid off, with one customer <a href="https://www.benzinga.com/markets/equities/24/11/41734875/palantirs-ai-gamble-pays-off-as-customer-revenue-from-single-customer-jumps-12x-in-under-8-month">increasing its annual recurring revenue twelvefold</a> in less than eight months after implementing the company's AI platform.
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41702294/apple-begins-shifting-iphone-17-production-in-india-cooks-china-optimism-and-more-this-week-in-apple?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Apple Begins Shifting iPhone 17 Production In India, Cook&#8217;s China Optimism, And More: This Week In Appleverse</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Global

Tech

PLTR

Palantir CEO Alex Karp Warns Europe Risks Doom Without AI

Outlook
In the Stimulation Services segment, the Company anticipates pricing and activity to decline in the fourth quarter. Due to our integrated model and prudent cost management, we are able to navigate cyclicality without sacrificing service and asset quality. Based on ongoing dialogue with operators we anticipate a recovery in activity in 2025 as compared to the fourth quarter of 2024, and we continue to field new inbound requests for additional integrated fleet deployments with the highest demand for electric and Tier 4 dual fuel or DGB technologies. Today, approximately 72% of our active fleets include e-fleet or natural gas-capable equipment.
The Proppant Production segment started to see incremental improvement as we moved through the third quarter, although natural gas-directed activity was subdued and West Texas remains highly competitive. We anticipate that pricing and volumes in the fourth quarter will be impacted by weaker demand. We continue to actively manage operating costs to partially mitigate the impact of lower profitability. We expect a recovery in activity in 2025 relative to the fourth quarter, with a more pronounced potential improvement in oil-levered regions.

ACDC

ProFrac Anticipates Decline In Stimulation Services And Proppant Production Segments In Q4 2024, With Recovery Expected in 2025

Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) CEO Elon Musk said on Monday that the company is not considering building a phone, refuting rumors.
What Happened: &#8220;No, we are not doing a phone,&#8221; Musk <a href="https://www.youtube.com/watch?v=7qZl_5xHoBw">said</a> in a podcast with Joe Rogan published on Monday. However, it is not because the company can&#8217;t do it, the CEO said. 
&#8220;We could do a phone since like the operating system in Tesla &#8211; it&#8217;s Linux-based &#8211; but we have written a massive amount of software on top of that. So probably Tesla is in a better position to create a new phone that&#8217;s not Android or iPhone than maybe any company in the world but it is not something we want to do unless we have to,&#8221; Musk said.
The company will have to make a phone if Apple or Google start censoring apps or acting like &#8220;gatekeepers,&#8221; the CEO added.
Tesla currently has its &#8220;plate full&#8221; with its efforts into electric vehicles, enabling autonomous driving, and robotics, Musk said while adding that making a phone would be &#8220;a huge pain the ass.&#8221;
Why It Matters: Musk first hinted at making a phone in November 2022, following his acquisition of Twitter, now rebranded as&nbsp;X, amidst uncertainty about the microblogging platform&#8217;s&nbsp;status on mainstream app stores.
Musk in June gave mixed signals about the company&#8217;s plans to make a phone. One day he announced in a live stream on X that Tesla was not going to make a phone.
Two days later, the CEO said that his tech company X manufacturing a phone running on a custom open-source operating system in partnership with another smartphone maker is "<a href="https://www.benzinga.com/news/24/06/39265691/a-day-after-shutting-down-tesla-phone-rumors-elon-musk-says-it-is-not-out-of-the-question" target="_blank" rel="noreferrer noopener">not out of the question</a>."
Musk <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/06/39306037/tesla-bull-adam-jonas-thinks-tesla-will-make-a-phone-elon-musk-hopes-it-wont-be-nee">later clarified</a> that Tesla could make a phone but he hopes that it is not &#8220;needed.&#8221;
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41736208/gm-crosses-300k-ev-deliveries-in-us-since-2016-but-its-still-over-40-lower-than-teslas-sales-in-the" target="_blank" rel="noreferrer noopener">GM Crosses 300K EV Deliveries In US Since 2016, But It's Still Over 40% Lower Than Tesla's Sales In The First 9 Months Of 2024</a></li>
</ul>
Photo courtesy: Shutterstock

TSLA

Elon Musk Rejects Rumors Of A Tesla Phone, But Says The EV Giant Will Have To Make One If This Happens

<a href="https://www.nytimes.com/2024/11/05/us/politics/dixville-notch-election-vote-results.html">https://www.nytimes.com/2024/11/05/us/politics/dixville-notch-election-vote-results.html</a>
&nbsp;

Election Day Begins With Dixville Notch Midnight Vote - It's a Harris-Trump Tie In 6 Vote Tally

ProFrac Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACDC#NASDAQ">ACDC</a>) reported quarterly sales of $575.300 million which beat the analyst consensus estimate of $560.713 million by 2.60 percent. This is a 0.19 percent increase over sales of $574.200 million the same period last year.

ProFrac Holding Q3 Sales $575.300M Beat $560.713M Estimate, Net loss $43.5M Compared To Net Loss Of $17.9M YoY

Macro Economic Events

Econ #s

Economics

U.K. Composite Purchasing Managers' Index For October 51.8 Vs. 51.7 Est.; 52.6 Prior

U.K. Services Purchasing Managers Index For October 52.0 Vs. 51.8 Est.; 52.4 Prior

Wedbush analyst Yun Zhong assumes MoonLake (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLTX#NASDAQ">MLTX</a>) with a Outperform rating and lowers Price Target of $73.

Price Target

Initiation

Analyst Ratings

MLTX

Wedbush Assumes MoonLake at Outperform, Lowers Price Target of $73

Wedbush analyst Yun Zhong initiates coverage on Rezolute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLT#NASDAQ">RZLT</a>) with a Outperform rating and announces Price Target of $12.

RZLT

Wedbush Initiates Coverage On Rezolute with Outperform Rating, Announces Price Target of $12

Wedbush analyst Yun Zhong initiates coverage on Protagonist Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTGX#NASDAQ">PTGX</a>) with a Outperform rating and announces Price Target of $58.

PTGX

Wedbush Initiates Coverage On Protagonist Therapeutics with Outperform Rating, Announces Price Target of $58

In a recent study, the National Retail Federation (NRF) warns that Donald Trump&#8217;s proposed tariffs could significantly impact American consumers, potentially reducing annual spending by $78 billion.
What Happened: The NRF study highlights the potential consequences of Trump&#8217;s tariff proposal on consumer goods, particularly those imported from China. The report, released on Monday, suggests that the tariffs could lead to increased prices on essential items such as apparel, toys, and appliances, affecting consumer spending habits, Reuters reported.
Jonathan Gold, NRF&#8217;s vice president of supply chain and customs policy, emphasized the reliance of retailers on imports to offer a diverse range of affordable products. The proposed tariffs, which include a 10% universal tariff on all imports and a possible 60% to 100% tariff on Chinese imports, could disproportionately impact low-income families as costs are passed on to consumers.
See Also: <a href="https://www.benzinga.com/news/24/11/41701311/scaramucci-says-trump-should-be-taken-into-custody-over-alleged-threat-against-liz-cheney?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Scaramucci Says Trump &#8216;Should Be Taken Into Custody&#8217; Over Alleged Threat Against Liz Cheney</a>
The NRF also projects a modest growth in holiday sales, expecting an increase of up to 3.5% to $989 billion, marking the slowest growth in six years.
Why It Matters: The proposed tariffs have sparked significant controversy, with a <a href="https://www.benzinga.com/startups/24/10/41561517/trump-pushes-forward-with-controversial-tariff-plan-despite-growing-backlash-from-voters-who-strongl">growing backlash from voters</a> who oppose the plan. An NBC News poll revealed that 44% of voters are less likely to support a candidate advocating for universal tariffs, highlighting the divisive nature of the issue amid economic challenges like inflation and fragile supply chains.
Furthermore, global concerns have been raised about the <a href="https://www.benzinga.com/markets/equities/24/10/41592365/trump-tariffs-will-be-negative-not-just-for-emerging-markets-but-across-the-world-says-singapore">potential negative impact</a> of Trump&#8217;s tariffs. Singapore&#8217;s state-owned investment firm, Temasek, warned that a Trump re-election could slow global growth, affecting U.S. companies and financial markets. The firm expressed concerns about increased uncertainty due to tariffs, which could lead to a stronger dollar and higher rates.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/politics/24/11/41732623/bakery-that-often-predicts-election-outcomes-has-this-candidate-winning-in-trump-harris-battle-d?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bakery That Often Predicts Election Outcomes Has This Candidate Winning In Trump, Harris Battle: &#8216;Doughmacracy For All!&#8217;</a></li>
</ul>
Image via Flickr
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Trump Tariff Proposed May Cost Americans $78B In Spending: Study

Zoomcar Holdings, Inc. ("Zoomcar" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>), the Nasdaq-listed leading marketplace for self-drive car sharing, announced a major expansion in its customer support efforts, doubling its customer support team to ensure faster, more efficient assistance for both Hosts and Guests on its platform. This expansion marks a significant step in addressing customer feedback and improving overall service quality.
&nbsp;
In a key initiative, Zoomcar has also launched a dedicated team called Host Success Team, to assist new Hosts in onboarding their vehicles and optimising earnings. This specialised team guides Hosts through every stage of their journey on the platform, providing continuous support to help them thrive.
In addition to expanding the team, Zoomcar has moved to a multi-channel support model. This now includes inbound and outbound calls, chatbot based ticketing support and a <a href="https://press.zoomcar.com/in/zoomcar-pioneers-ai-innovation-unveils-beta-ai-assistant-to-enhance-host-and-guest-experience/">Generative AI (Gen AI) Assistant</a>&nbsp;that offers 24x7 assistance. This enhanced customer support framework has already led to an 50% reduction in in-app escalations, with continued improvements expected as the new measures take full effect.

ZCAR

Zoomcar Expands Customer Support, Doubles Team for Faster Service

Lilium N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LILM#NASDAQ">LILM</a>), a leading electric aircraft manufacturer and pioneer in Regional Air Mobility (RAM), announces that it has appointed KPMG to conduct an open, transparent and fair M&amp;A process. First investor briefings will start soon.
This followed the local court of Weilheim's approval of the insolvency filing of Lilium's German subsidiaries and the court's granting of Lilium's application for self-administration.
Preliminary insolvency proceedings under self-administration are court-ordered restructuring proceedings aimed at preserving the business. The management remains in charge and leads the business through the proceedings, supported by restructuring experts.
The court has appointed to the German subsidiaries' Boards of Management with immediate effect two restructuring-experienced lawyers, Prof. Dr. Gerrit Hölzle and Dr. Thorsten Bieg as Chief Insolvency Officers (CIOs). Both have already successfully advised a large number of companies in crisis situations. Most recently, they worked for Senvion and The Social Chain AG, among others. They will now oversee the reorganization of Lilium's German subsidiaries.
The Local Court of Weilheim has also appointed attorney Mr. Ivo-Meinert Willrodt, Managing Partner at PLUTA Rechtsanwalts GmbH, as the provisional custodian. The restructuring expert is an attorney and specialist lawyer for insolvency and restructuring law and has already acted as trustee for the solar car start-up Sono Motors and the drone manufacturer EMT, among others. His role is to protect the interests of the creditors in the proceedings.

LILM

Lilium Taps KPMG for M&A as German Subsidiaries Enter Insolvency

Adtran today announced that the Centre Régional Informatique et d'Applications Numériques de Normandie (CRIANN) is using its FSP 3000 optical transport technology and ALM fiber monitoring platform to boost the capacity and resilience of its research and education network, thanks to the financial support of the Normandy Region. By integrating Adtran's solution, the Normandy-based supercomputing center and provider of high-performance digital infrastructure is ensuring faster and more reliable connectivity for the region's scientific and academic institutions. Adtran's Elite partner Axians also played a key role in the installation and continues to deliver maintenance and support.

ADTN

Adtran Powers Faster, Reliable Network for Normandy's Research and Education with Optical Transport Tech

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Supernus Pharmaceuticals (SUPN – Research Report) an...

Analysts Offer Insights on Healthcare Companies: Supernus Pharmaceuticals (SUPN) and Tyra Bioscience (TYRA)

Tyra raised to buy by BofA ahead of TYRA-300 data readout

Tyra Biosciences (TYRA) announced clinical proof-of-concept data for TYRA-300 in patients with metastatic urothelial – mUC – cancer from its ongoin...

Tyra Biosciences' TYRA-300 shows anti-tumor activity in proof-of-concept trial

Tyra Bioscience ( ($TYRA) ) has provided an announcement. Tyra Biosciences announced promising interim clinical results for TYRA-300 in metastatic ...

Tyra Bioscience Shows Promise with TYRA-300 Results

In a report released today, Robert Driscoll from Wedbush maintained a Buy rating on Tyra Bioscience (TYRA – Research Report), with a price target o...

Tyra Bioscience (TYRA) Gets a Buy from Wedbush

Tyra stock plunges 17% amid TYRA-300 study data release

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. 1. STOCK NEWS: A U.S. judge has blocked the proposed ...

Judge blocks Tapestry-Capri deal, Centene reports Q3 beat: Morning Buzz

H.C. Wainwright raised the firm's price target on Tyra Biosciences (TYRA) to $32 from $30 and keeps a Buy rating on the shares. The firm says TYRA-...

Tyra Biosciences price target raised to $32 from $30 at H.C. Wainwright

H.C. Wainwright analyst Mitchell Kapoor maintained a Buy rating on Tyra Bioscience (TYRA – Research Report) today and set a price target of $32.00....

Buy Recommendation for Tyra Bioscience Based on Promising Clinical Data and Safety Profile of TYRA-300

Tyra Biosciences (TYRA) announced that the FDA cleared its Investigational New Drug application for Tyra-300 allowing the company to proceed with a...

Tyra Biosciences granted IND clearance from FDA for Phase 2 study of Tyra-300

AAPL

BYON

CPRI

DBRG

DECK

JOBY

MSFT

NYCB

PIPR

RLAY

SNYNF

SUPN

TMHC

TMUS

TYRA

Press Releases

Tyra Biosciences to Present at Upcoming Investor Conferences

Tyra Biosciences Announces Preclinical Proof-of-Concept Results with TYRA-300 in Hypochondroplasia (HCH)

Tyra Biosciences Reports Second Quarter 2024 Financial Results and Highlights

Small Cap

TYRA Investors Have Opportunity to Join Tyra Biosciences, Inc. Securities Fraud Investigation with the Schall Law Firm

Tyra Biosciences Appoints Doug Warner, M.D., as Chief Medical Officer

Tyra Biosciences to Present at the 2024 Cantor Global Healthcare Conference

Tyra Biosciences Announces Late-Breaking Oral Presentation on Preliminary Safety and Anti-Tumor Activity of TYRA-300 from SURF301 at the 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics (ENA 2024)

Tyra Biosciences to Host Conference Call on Interim Clinical Data of TYRA-300 from SURF301 Phase 1/2 Study on October 25, 2024, at 8am ET

Tyra Biosciences Reports Interim Clinical Proof-of-Concept Data for TYRA-300, an Investigational Oral FGFR3-Selective Inhibitor, in Phase 1/2 SURF301 Study in Patients with Metastatic Urothelial Cancer (mUC)

Comments

Tyra Biosciences

Vendite allo scoperto

Tyra Biosciences (NASDAQ:TYRA) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO